Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Clinical trial NCT01621256 · COMPLETED
Trial details
- NCT number
- NCT01621256
- Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2018-09-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.